BIOMARIN PHARMACEUTICAL INC Accrued Vacation, Current
BIOMARIN PHARMACEUTICAL INC (BMRN) had Accrued Vacation, Current of $19.73 million as of 2016-06-30, per its 10-Q filed 2016-08-08.
Discontinued › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedVacationCurrent · last filed 2016-08-08
- 2016-06-30: Accrued Vacation, Current $19.73M.
- 2016-03-31: Accrued Vacation, Current $19.70M.
- 2015-12-31: Accrued Vacation, Current $16.92M.
- 2015-09-30: Accrued Vacation, Current $15.45M.
| Period end | Accrued Vacation, Current |
|---|---|
| 2016-06-30 | $19.73M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $19.70M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $16.92M 10-Q · filed 2016-08-08 |
| 2015-09-30 | $15.45M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $16.00M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $15.87M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $12.54M 10-K · filed 2016-02-29 |
| 2014-09-30 | $11.84M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $12.56M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $12.21M 10-Q · filed 2014-05-02 |
| 2013-12-31 | $10.49M 10-K · filed 2015-03-02 |
| 2013-09-30 | $9.72M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $10.41M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $10.04M 10-Q · filed 2013-04-29 |
| 2012-12-31 | $8.40M 10-K · filed 2014-02-26 |
| 2012-09-30 | $7.89M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $8.23M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $7.70M 10-Q · filed 2012-04-30 |
| 2011-12-31 | $6.53M 10-K · filed 2013-02-26 |
| 2011-09-30 | $6.47M 10-Q · filed 2011-10-31 |
| 2011-06-30 | $6.90M 10-Q · filed 2011-08-01 |
| 2010-12-31 | $5.63M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |